Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
NSC23766
i
Other names:
NSC23766
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
University of Oslo
Drug class:
RAC1 inhibitor
Related drugs:
‹
MBQ-167 (0)
MBQ-167 (0)
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
PTTG1 overexpression
Clear Cell Renal Cell Carcinoma
PTTG1 overexpression
Clear Cell Renal Cell Carcinoma
NSC23766
Sensitive: D – Preclinical
NSC23766
Sensitive
:
D
NSC23766
Sensitive: D – Preclinical
NSC23766
Sensitive
:
D
NPM1 mutation
Acute Myelogenous Leukemia
NPM1 mutation
Acute Myelogenous Leukemia
NSC23766
Sensitive: D – Preclinical
NSC23766
Sensitive
:
D
NSC23766
Sensitive: D – Preclinical
NSC23766
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login